Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis.

Agema, Willem R P

Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis. [electronic resource] - Thrombosis and haemostasis May 2004 - 986-90 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0340-6245

10.1160/TH03-11-0668 doi


Coronary Artery Disease--drug therapy
Disease Progression
Drug Resistance--genetics
Genotype
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Lipopolysaccharide Receptors--genetics
Middle Aged
Pharmacogenetics
Polymorphism, Single Nucleotide--physiology
Pravastatin--pharmacology
Promoter Regions, Genetic--genetics
Receptors, Immunologic--genetics